Literature DB >> 7333344

Aging, cigarette smoking and oral theophylline requirement.

T Talseth, N P Boye, J Kongerud, J E Bredesen.   

Abstract

In a prospective study in 73 patients with obstructive pulmonary disease, aged 63.5 +/- 13.5 years (SD), it was found that theophylline dose, cigarette smoking and age were all significant determinants of the steady-state trough plasma theophylline level during oral administration of the drug. As the predictive efficiency of the three factors combined amounted only to 25%, firm dosage recommendations cannot be made. Even among elderly patients, tobacco smokers had significantly lower plasma concentrations of theophylline. It is suggested that in order to obtain trough plasma concentrations of 50 mumol/l (approximately equal to 9 micrograms/ml), a non-smoking 50 year-old patient would require 9.8 mg/kg/day of oral theophylline, the dose increasing to 14.2 mg/kg/day in smokers of the same age. These doses should probably be reduced by 15-20% in 75 year-old patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333344     DOI: 10.1007/bf00609585

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Relationship of urinary metabolites of theophylline to serum theophylline levels.

Authors:  J W Jenne; H T Nagasawa; R D Thompson
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

2.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

3.  The influence of cigarette smoking and sex on theophylline disposition.

Authors:  J R Powell; J F Thiercelin; S Vozeh; L Sansom; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1977-07

4.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Pharmacokinetics of theophylline in ten elderly patients.

Authors:  F Nielsen-Kudsk; I Magnussen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-03

6.  Intravenous theophylline therapy: nomogram guidelines.

Authors:  W J Jusko; J R Koup; J W Vance; J J Schentag; P Kuritzky
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

7.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.

Authors:  A J Wood; R E Vestal; G R Wilkinson; R A Branch; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

8.  Oral aminophylline therapy. Increased dosage requirements in children.

Authors:  D E Zaske; K W Miller; E L Strem; S Austrian; P B Johnson
Journal:  JAMA       Date:  1977-04-04       Impact factor: 56.272

9.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

10.  Oral theophylline dosage for the management of chronic asthma.

Authors:  R Wyatt; M Weinberger; L Hendeles
Journal:  J Pediatr       Date:  1978-01       Impact factor: 4.406

View more
  3 in total

1.  [Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].

Authors:  W Mühlberg; D Platt; M Bauer; U Salzner
Journal:  Klin Wochenschr       Date:  1987-07-15

2.  The effect of age on theophylline clearance in normal subjects.

Authors:  W C Randolph; J J Seaman; B Dickson; K E Peace; W O Frank; M D Young
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

3.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.